These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 31938938)

  • 1. Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy.
    Tadros AB; Moo TA; Stempel M; Zabor EC; Khan AJ; Morrow M
    Breast Cancer Res Treat; 2020 Feb; 180(1):197-205. PubMed ID: 31938938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases.
    Mamtani A; Patil S; Van Zee KJ; Cody HS; Pilewskie M; Barrio AV; Heerdt AS; Morrow M
    Ann Surg Oncol; 2016 Oct; 23(11):3481-3486. PubMed ID: 27169771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing Axillary Management in Clinical T1-2N0 Mastectomy Patients with Positive Sentinel Lymph Nodes.
    Kantor O; Means J; Grossmith S; Dey T; Bellon JR; Mittendorf EA; King TA
    Ann Surg Oncol; 2022 Feb; 29(2):972-980. PubMed ID: 34467507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy.
    Kuru B; Yuruker S; Sullu Y; Gursel B; Ozen N
    J Invest Surg; 2019 Jan; 32(1):48-54. PubMed ID: 28945489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Potential Impact of AMAROS on the Management of the Axilla in Patients with Clinical T1-2N0 Breast Cancer Undergoing Primary Total Mastectomy.
    Moossdorff M; Nakhlis F; Hu J; Barry WT; Losk K; Haskett C; Smidt ML; King TA
    Ann Surg Oncol; 2018 Sep; 25(9):2612-2619. PubMed ID: 29855827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy.
    Verreck EEF; van Steenhoven JEC; Kuijer A; van Maaren MC; Simons JM; Siesling S; van Dalen T
    Ann Surg Oncol; 2023 Sep; 30(9):5623-5632. PubMed ID: 37225832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choice of Mastectomy May Increase the Extent of Axillary Surgery in Women with Breast Cancer.
    Zaveri S; Romanoff A; Hirt L; Thompson L; Pisapati KV; Weltz C; Schmidt H; Port E
    Am Surg; 2022 Nov; 88(11):2686-2694. PubMed ID: 35081002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omission of axillary lymph node dissection for breast cancer patients with three or more positive sentinel lymph nodes.
    Prathibha S; White M; Kolbow M; Hui JYC; Brauer D; Ankeny J; Jensen EH; LaRocca CJ; Marmor S; Tuttle TM
    Breast Cancer Res Treat; 2024 May; 205(1):127-133. PubMed ID: 38281296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidisciplinary Management of the Axilla in Patients with cT1-T2 N0 Breast Cancer Undergoing Primary Mastectomy: Results from a Prospective Single-Institution Series.
    Grossmith S; Nguyen A; Hu J; Plichta JK; Nakhlis F; Cutone L; Dominici L; Golshan M; Duggan M; Carter K; Rhei E; Barbie T; Calvillo K; Nimbkar S; Bellon J; Wong J; Punglia R; Barry W; King TA
    Ann Surg Oncol; 2018 Nov; 25(12):3527-3534. PubMed ID: 29868979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative Pathology Assessment May Lead to Overtreatment of the Axilla in Clinically Node-Negative Breast Cancer Patients Undergoing Upfront Mastectomy.
    Pride RM; Glass CC; Nakhlis F; Laws A; Weiss AC; Bellon JR; Mittendorf EA; King TA; Kantor O
    Ann Surg Oncol; 2023 Oct; 30(10):5978-5987. PubMed ID: 37436607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omitting axillary lymph node dissection after positive sentinel lymph node in the post-Z0011 era: Compliance with NCCN and ASCO clinical guidelines and Z0011 criteria in a large prospective cohort.
    Costaz H; Boulle D; Bertaut A; Rouffiac M; Beltjens F; Desmoulins I; Peignaux K; Ladoire S; Causeret S; Loustalot C; Padeano MM; Vincent L; Jankowski C; Arnould L; Coutant C
    Bull Cancer; 2022 Mar; 109(3):268-279. PubMed ID: 34838310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution in practice patterns of axillary management following mastectomy in patients with 1-2 positive sentinel nodes.
    Weiss A; Lin H; Babiera GV; Bedrosian I; Shaitelman SF; Shen Y; Kuerer HM; Mittendorf EA; Caudle AS; Hunt KK; Hwang RF
    Breast Cancer Res Treat; 2019 Jul; 176(2):435-444. PubMed ID: 31025270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axillary Surgery for Early-Stage, Node-Positive Mastectomy Patients and the Use of Postmastectomy Chest Wall Radiation Therapy.
    Gaines S; Suss N; Barrera E; Pesce C; Kuchta K; Winchester DJ; Yao K
    Ann Surg Oncol; 2018 Aug; 25(8):2220-2228. PubMed ID: 29626303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of completion axillary dissection for patients with cT1-2N0 breast cancer undergoing total mastectomy with positive sentinel lymph nodes.
    Schwieger L; Postlewait LM; Subhedar PD; Geng F; Liu Y; Gillespie T; Arciero CA
    J Surg Oncol; 2024 Mar; 129(3):468-480. PubMed ID: 37955191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intraoperative assessment of sentinel nodes - Standards and controversies.
    van der Noordaa MEM; Vrancken Peeters MTFD; Rutgers EJT
    Breast; 2017 Aug; 34 Suppl 1():S64-S69. PubMed ID: 28673534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Post Mastectomy Radiation Therapy in Patients Receiving Axillary Lymph Node Dissection After Positive Sentinel Lymph Node Biopsy.
    Stauder MC; Caudle AS; Allen PK; Shaitelman SF; Smith BD; Hoffman KE; Buchholz TA; Chavez-Macgregor M; Hunt KK; Meric-Bernstam F; Woodward WA
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):637-44. PubMed ID: 27681760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microscopic Extracapsular Extension in Sentinel Lymph Nodes Does Not Mandate Axillary Dissection in Z0011-Eligible Patients.
    Barrio AV; Downs-Canner S; Edelweiss M; Van Zee KJ; Cody HS; Gemignani ML; Pilewskie ML; Plitas G; El-Tamer M; Kirstein L; Capko D; Patil S; Morrow M
    Ann Surg Oncol; 2020 May; 27(5):1617-1624. PubMed ID: 31820212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of T Stages on the Choice of Axillary Evaluation Modality in Breast Cancer Patients With 1-2 Sentinel Lymph Node Metastases.
    Liu D; Chang L; Zhao X; Dai L; Cui H; Liu P; Zhai Z; Wu H; Ma X; Kang H
    Clin Breast Cancer; 2024 Jun; 24(4):e232-e243.e1. PubMed ID: 38368246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of frozen-section analysis of sentinel lymph node and lumpectomy margin status on reoperation rates in patients undergoing breast-conservation therapy.
    McLaughlin SA; Ochoa-Frongia LM; Patil SM; Cody HS; Sclafani LM
    J Am Coll Surg; 2008 Jan; 206(1):76-82. PubMed ID: 18155571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage migration in breast cancer: surgical decisions concerning isolated tumour cells and micro-metastases in the sentinel lymph node.
    de Widt-Levert L; Tjan-Heijnen V; Bult P; Ruers T; Wobbes T
    Eur J Surg Oncol; 2003 Apr; 29(3):216-20. PubMed ID: 12657229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.